0001209191-23-000935.txt : 20230104 0001209191-23-000935.hdr.sgml : 20230104 20230104162518 ACCESSION NUMBER: 0001209191-23-000935 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230101 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DesJardin Michael A. CENTRAL INDEX KEY: 0001512985 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 23506823 MAIL ADDRESS: STREET 1: C/O JAZZ PHARMACEUTICALS, INC. STREET 2: 3180 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-01 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001512985 DesJardin Michael A. C/O HORIZON THERAPEUTICS PLC, 70 ST. STEPHEN?S GREEN DUBLIN L2 D02 E2X4 IRELAND 0 1 0 0 EVP, Technical Operations Ordinary Shares 2023-01-01 4 M 0 21772 A 104395 D Ordinary Shares 2023-01-01 4 F 0 9561 113.80 D 94834 D Performance Restricted Stock Units (PSUs) 2023-01-01 4 M 0 21772 0.00 D Ordinary Shares 21772 0 D Each PSU represents a contingent right to receive one ordinary share of the Issuer. The ordinary shares subject to the PSUs vested on January 1, 2023. /s/ Patrick McIlvenny, Attorney-in-Fact 2023-01-04